EU lights touch paper for another round of medical protectionism

Coronavirus 472 European Union 706 Health Care 292 India 430 Mexico 775 Tariffs 1704 U.S. 4856 United Kingdom 306

The European Commission has implemented an export authorization scheme for SARS-COV-2 vaccines covering drugs bought under the Accelerated Purchase Program. That follows a delay in ramping up shipments from AstraZeneca even as the firm’s U.K. plant ran as expected. While the measure is not an export ban per se it is likely to drive a new round of medical protectionism. The U.S. and China accounted for 44.5% and 11.1% respectively of the EU’s vaccine exports in the 12 months to Oct. 31. Exports of vaccines to the U.K., mostly linked to seasonal flu, declined by 61.6% year over year in the...

Copyright © 2021 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.